Sleep Goal-focused Online Access to Lifestyle Support (SGOALS)

November 1, 2023 updated by: Marquis Hawkins, University of Pittsburgh

Sleep GOALS (Goal-focused Online Access to Lifestyle Support), an Internet Assisted Diet, Physical Activity, and Sleep Weight Loss Intervention for Postpartum Women

The overall goal of the study is to develop a novel weight loss intervention for postpartum people by providing strategies to improve sleep, diet, and physical activity behaviors. In this study, we will recruitment and enroll 40 postpartum people and randomize them to receive the Sleep GOALS intervention or education control to evaluate the intervention's feasibility, acceptability, and preliminary efficacy.

Study Overview

Status

Recruiting

Study Type

Interventional

Enrollment (Estimated)

40

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

    • Pennsylvania
      • Pittsburgh, Pennsylvania, United States, 15261
        • Recruiting
        • University of Pittsburgh

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • Stated willingness to comply with all study procedures and availability for the duration of the study,
  • Primiparous, singleton pregnancy,
  • Between 3+1 and 6+1 months postpartum,
  • Has a body mass index >25 kg/m2,
  • Physically inactive, defined as self-reporting <150 minutes/week of moderate-to-vigorous intensity physical activity,
  • Endorse >1 indicator of poor sleep health based on the RU_SATED questionnaire, and
  • Has smartphone and home Internet access

Exclusion Criteria:

  • current use of medications that affect weight,
  • currently pregnant or plan to become pregnant during the study period (18 weeks), and
  • participating in another weight loss intervention.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Prevention
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Double

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Sleep GOALS
Weekly 15-to-20 minute educational video each, a commercial activity tracker (e.g., Fitbit) to monitor sleep and physical activity, wireless scale to monitor weight, and a lifestyle coach who will provide personalized support.
Web-based interventions
Active Comparator: Education
Brochures that provide tips for improving sleep health, diet, and physical activity
Brochures from the American Academy of Sleep Medicine (e.g., sleep hygiene, sleep in women) and SNAP education connection (e.g., family-friendly activities, meal planning)

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Recruitment/Enrollment - Number of the total sample
Time Frame: Baseline
The number of participants enrolled in 12 months
Baseline
Recruitment/Enrollment - Proportion of ethnic minority
Time Frame: Baseline
The proportion of ethnic minority
Baseline
Retention rates
Time Frame: Post-intervention at week 17
1-Attrition rates, % with complete post-intervention data collection
Post-intervention at week 17
Engagement - Number of modules completed
Time Frame: Week 1 to 16
The number of modules completed within 16 weeks
Week 1 to 16
Engagement - Number of self-monitoring of diet, sleep and physical activity weekly
Time Frame: Week 1 to 16
The number of weeks in which self-monitoring of diet, sleep, and physical activity is performed at least once a week
Week 1 to 16
Engagement - Number of weekly weigh-ins
Time Frame: Week 1 to 16
The number of weeks in which weigh-in is performed at least once a week
Week 1 to 16
Engagement - Total time logged in
Time Frame: Week 1 to 16
Total time logged in during the 16-week intervention
Week 1 to 16
Acceptability - Proportion of agreeing
Time Frame: Week 1 to Post-intervention at week 17

Participant ratings on the intervention delivery; behavior change curricula; action plan; intervention platform.

The questionnaire asks participants to provide answers on a 5-point scale (1=don't agree at all to 5=totally agree) to 39 items about the intervention delivery (e.g., logical, understandable), curricula (e.g., was it logical, relevant, instructive), action plans (e.g., useful, easy to follow), and intervention platform (e.g., user friendly).

Week 1 to Post-intervention at week 17

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Weight change
Time Frame: Baseline and Post-intervention at week 17
Baseline and post-intervention differences in weight. Weight will be measured with a digital scale, with the participant wearing light clothing and no shoes at baseline and post-intervention.
Baseline and Post-intervention at week 17
Postpartum weight retention
Time Frame: Post-intervention at week 17
Pre-pregnancy and post-intervention differences in weight. Participants will self-report pre-pregnancy weight, and post-intervention weight will be measured with a digital scale, with the participant wearing light clothing and no shoes. The power-to-weight ratio (PWR) will be estimated as the difference in measured weight at post-intervention and self-reported pre-pregnancy weight.
Post-intervention at week 17

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Marquis Hawkins, PhD, University of Pittsburgh

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

September 21, 2023

Primary Completion (Estimated)

December 1, 2024

Study Completion (Estimated)

December 1, 2024

Study Registration Dates

First Submitted

May 23, 2023

First Submitted That Met QC Criteria

July 3, 2023

First Posted (Actual)

July 12, 2023

Study Record Updates

Last Update Posted (Actual)

November 2, 2023

Last Update Submitted That Met QC Criteria

November 1, 2023

Last Verified

November 1, 2023

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • STUDY23020169
  • 1K01HL161439-01 (U.S. NIH Grant/Contract)

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

YES

IPD Plan Description

Individual participant data that underlie the results reported in the article after deidentification (text, tables, figures, and appendices)

IPD Sharing Time Frame

Data will be made available after primary outcome manuscripts are published. Data will remain available in de-identified format with no end date specified.

IPD Sharing Access Criteria

Data will be shared with investigators whose proposed use of the data has been approved by an independent review committee identified for this purpose. Researchers requesting use of data must submit their request in writing to the MPIs, including the purpose for which they are requesting use of the data. These requests will be reviewed by the Investigators and will require engaging in a Data Use Agreement (DUA), in cooperation with the University of Pittsburgh. Data will be shared to achieve aims in the approved proposal. We plan to use the Open Science generalist platform to share data, as requested. As the study is completed, we will share data using the NIDA data share website.

IPD Sharing Supporting Information Type

  • STUDY_PROTOCOL
  • SAP
  • ANALYTIC_CODE

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Weight Loss

Clinical Trials on Sleep GOALS

3
Subscribe